The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations

Journal of Thoracic and Cardiovascular Surgery

Volumn 111, Issue 4, 1996, Pages 742-752

  Ferguson Jr , T B ^a   Ferguson, C L ^a   Crites, K ^a   Crimmins Reda, P ^a   Pennington, D G ^a   Shemin, R J ^a   Arbulu, A ^a   Moulton, A L ^a  

^a Division of Cardiothoracic Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; DEFIBRILLATOR; HOSPITAL CHARGE; HOSPITAL COST; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MEDICARE; PACEMAKER; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REIMBURSEMENT;

EID: 0029935384     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(96)70334-3     Document Type: Article

References (35)

1. TB Ferguson Jr The future of arrhythmia surgery J Card Electrophysiol 7 1995 621 635
2. GH Bardy B Hofer G Johnson Implantable transvenous cardioverter-defibrillators Circulation 87 1993 1152 1168
3. AJ Moss Influence of the implantable cardioverter defibrillator on survival: retrospective studies and prospective trials Prog Cardiovasc Dis 36 1993 85 88
4. SJ Connoly S Yusuf Evaluation of the implantable cardioverter defibrillator in survivors of cardiac arrest: the need for randomized trials Am J Cardiol 69 1992 959 962
5. SS Barold RS Sanders Rate-adaptive cardiac pacing: cost versus technology versus patient benefit Am Heart J 126 1993 1828 1834
6. AD Bernstein V Parsonnet Survey of cardiac pacing in the United States in 1989 Am J Cardiol 69 1992 331 338
7. TB Ferguson Jr BD Lindsay JP Boineau Should surgeons still be implanting pacemakers? Ann Thorac Surg 57 1994 588 597
8. DP Zipes Implantable cardioverter-defibrillator: lifesaver or a device looking for a disease? Circulation 89 1994 2934 2936
9. AM Kramer Health care for elderly persons—myths and realities N Engl J Med 332 1995 1027 1028
10. MJ Griffith RS Bexton JM McComb Financial audit of antitachycardia pacing for the control of recurrent supraventricular tachycardia Br Heart J 69 1993 272 275
11. MA De Belder NJ Linker S Jones AJ Camm DE Ward Cost implication of the British Pacing and Electrophysiology Group's recommendations for pacing Br Med J 305 1992 861 865
12. M Krucoff F Chu D McCallum S Perry New medical technologies in a cost containment environment: implantable antitachyarrhythmia devices PACE 10 1987 2 20
13. MH Anderson Predicting the cost-efficacy of implantable cardioverter-defibrillators: use of a model to study new and existing indications RM Luceri Sudden cardiac death: strategies for the 1990s 1992 : Peritus Corporation Miami Lakes 159 177
14. DP Zipes Are implantable cardioverter-defibrillators better than conventional antiarrhythmic drugs for survivors of cardiac arrest? Circulation 91 1995 2115 2118
15. R Ott T Tanner B Henderson Managed care and the cardiac patient 1995 : Hanley & Belfus Philadelphia
16. DJ Shulkin JJ Escarce C Enarson JM Eisenberg Impact of the Medicare fee schedule on an academic department of medicine JAMA 266 1991 3000 3003
17. HR Giezl Managed care: organizational structures and litigation prospects R Ott T Tanner B Henderson Managed care and the cardiac patient 1995 : Hanley & Belfus Philadelphia 9 31
18. HR Burstin SR Lipsitz S Udvarhelyi TA Brennan The effect of hospital financial characteristics on quality of care JAMA 270 1993 845 849
19. B Jordan Contracting financial and service matrix R Ott T Tanner B Henderson Managed care and the cardiac patient 1995 : Hanley & Belfus Philadelphia 31 38
20. Zipes DP, Roberts D, PCD Investigators. Results of the world-wide study of the implantable pacemaker, cardioverter-defibrillator: a comparison of epicardial and endocardial lead systems. Circulation [In press].
21. SA Strickenberger M Niebauer KC Man Comparison of implantation of nonthoracotomy defibrillators in the operating room versus the electrophysiology laboratory Am J Cardiol 75 1995 255 257
22. BD Williamson KC Man M Niebauer The economic impact of transvenous defibrillation lead systems PACE 17 1994 2297 2303
23. SK Schleuning Managed care: an overview and prescription for change R Ott T Tanner B Henderson Managed care and the cardiac patient 1995 : Hanley & Belfus Philadelphia 3 7
24. T Tanner R Ott R Moscoso D Gutfinger P Fopiano Effective management of global fee services: the integration of interventional and cardiac surgical services R Ott T Tanner B Henderson Managed care and the cardiac patient 1995 : Hanley & Belfus Philadelphia 105 114
25. SO Nunain M Roelke T Trouton Limitations and late complications of third-generation automatic cardioverter- defibrillators Circulation 91 1995 2204 2213
26. E Daoud M Niebauer L Horwood Rise in chronic defibrillation threshold necessitating defibrillator lead system revision J Am Coll Cardiol 23 1995 408A
27. M Kupperman BR Luce B McGovern PJ Podrid JT Bigger JN Ruskin An analysis of the cost effectiveness of the implantable defibrillator Circulation 81 1990 91 100
28. EFD Wever RNW Hauer FJL van Capele Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarction sudden death survivors Circulation 91 1995 2195 2203
29. Ferguson TB Jr. Direct surgery versus ICD therapy for ischemic ventricular tachycardia. Ann Thorac Surg [In press].
30. B Phibbs HJL Marriott Complications of permanent transvenous pacing N Engl J Med 312 1985 1428 1432
31. V Parsonnet AD Bernstein BD Lindsay Pacemaker implantation complication rates: an analysis of some contributing factors J Am Coll Cardiol 13 1989 917 921
32. PF Mansfield DC Hohn BD Fornage MA Gregurich DM Ota Complications and failures of subclavian-vein catheterization N Engl J Med 331 1994 1735 1738
33. BJ Allen MA Brodsky Cost-effective management of congestive heart failure and cardiac arrhythmias in the managed care setting R Ott T Tanner B Henderson Managed care and the cardiac patient 1995 : Hanley & Belfus Philadelphia 229 234
34. J Lubitz J Beebe C Baker Longevity and Medicare expenditures N Engl J Med 332 1995 999 1003
35. SG Ray MJ Griffith S Jamieson RS Bexton RG Gold Impact of the recommendations of the British Pacing and Electrophysiology Group on the pacemaker prescription and on the immediate costs of pacing in the Northern Region Br Heart J 68 1992 531 534